Evolutionary Rates and Hbv: Issues of Rate Estimation with Bayesian Molecular Methods
Antiviral Therapy · 2013-04 · 18 (3_part_2) · 497-504
DOI: 10.3851/imp2656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antiviral Therapy, online erschienen am 01.04.2005. Verfasst von Remco Bouckaert und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Auckland, Auckland, New Zealand. remco@cs.auckland.ac.nz. Hauptthemen laut MEDLINE: Mutation Rate. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
HBV infection is a public health problem affecting approximately 2 billion people and leading to >350 million chronic carriers of the virus worldwide. Phylogenetic analysis can give valuable insight to help in clarifying the history of viral infections around the world and in elucidating routes of transmission of the different viral strains present in the infected host population. These analyses rely on an accurate estimate of the rate of mutations.
Methods
In this study, we investigated the robustness of rate estimations based on Bayesian analysis obtained so far and examined, in particular, the choice of prior for the substitution rate.
Results
Most previous studies have concentrated on estimating the parameters of simple demographic models for HBV, such as exponential growth and constant population size. Here, we introduce a method that automatically partitions the genome in components that show a different rate of mutation and fit different substitution models.
Conclusions
In conclusion, we find that, due to inaccuracy in the sampling dates from the samples where viral sequences were obtained, lack of a sufficiently large geographical and time spread of available and trustworthy sample dates, sensitivity to priors and model misspecification and rate estimation based on molecular methods, are not reliable. We suggest that rate estimates taking into account calibration points based on relevant historical events are more robust due to the lack of trustworthy sampling dates. For example, the known history of colonization of the Americas should be used to accurately study the current diversity of genotype F, which is the most frequent genotype in almost all Spanish speaking countries in South America.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Auckland, Auckland, New Zealand. remco@cs.auckland.ac.nz
Zitieren
APA
Bouckaert, R., Alvarado-Mora, M. V., & Pinho, J. R. (2013). Evolutionary Rates and Hbv: Issues of Rate Estimation with Bayesian Molecular Methods. Antiviral Therapy, 18(3_part_2), 497-504. https://doi.org/10.3851/imp2656
Vancouver
Bouckaert R, Alvarado-Mora MV, Pinho JR. Evolutionary Rates and Hbv: Issues of Rate Estimation with Bayesian Molecular Methods. Antiviral Therapy. 2013;18(3_part_2):497-504. doi:10.3851/imp2656
BibTeX
@article{Bouckaert2013,
author = {Bouckaert, Remco and Alvarado-Mora, Mónica V and Pinho, João R Rebello},
title = {Evolutionary Rates and Hbv: Issues of Rate Estimation with Bayesian Molecular Methods},
journal = {Antiviral Therapy},
year = {2013},
volume = {18},
number = {3_part_2},
pages = {497--504},
doi = {10.3851/imp2656}
}
EUVIMED